News, analysis, and evidence
Read the latest coverage, statements, analysis, and public-facing resources from Americans for Safe and Effective Medicines.
Explore ASEM
From ASEM
Americans for Safe and Effective Medicines Chief Policy Officer Fred Mills, PharmD, responds to FDA’s updated guidance on unapproved GLP-1 drugs used for weight loss and calls for enforcement against illegal marketing and distribution.
Selected reading
National Surveys
84% of consumers say FDA approval matters. Half of current GLP-1 users mistakenly believe compounded versions have it — and physicians are seeing the same confusion in their exam rooms. A one-page summary of ASEM’s consumer and physician survey findings.
DownloadReport
ASEM’s report on how illegal mass compounding is undermining patient safety — and what must happen next.
View Report
